Eurovacc Foundation

HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses

Patrizia Amelio, Damien Portevin, Jerry Hella et al. · Journal of Virology · 2018 · 78 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

Pierre‐Alexandre Bart, Ruth Goodall, Tristan Barber et al. · Vaccine · 2008 · 59 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial

Giuseppe Pantaleo, Holly Janes, Shelly Karuna et al. · The Lancet HIV · 2019 · 50 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

Juan García‐Arriaza, Beatriz Perdiguero, Jonathan L. Heeney et al. · Journal of Virology · 2015 · 38 citations

Life Sciences, Immunology, Microbiology +17

Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania

Patrizia Amelio, Damien Portevin, Klaus Reither et al. · PLoS neglected tropical diseases · 2017 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17